$0.95
+0.01 (+0.97%)
Open$0.95
Previous Close$0.94
Day High$0.98
Day Low$0.95
52W High$3.13
52W Low$0.53
Volume—
Avg Volume428.1K
Market Cap91.26M
P/E Ratio—
EPS$-5.54
SectorN/A
Analyst Ratings
Buy
10 analysts
Price Target
+313.7% upside
Current
$0.95
$0.95
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.37B | 1.26B | 17.89M |
| Net Income | -546,700,485 | -449,589,214 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -410,858,704 | -356,648,180 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.86 | -10.68% | — | 5.22B |
| PICS | Pics Nv | $10.49 | -9.22% | — | 1.50B |
| DMII | Drugs Made In America Acquis | $10.03 | +0.00% | 152.6 | 638.91M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.84B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.54 | -0.01% | 62.2 | 606.86M |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | +0.10% | 96.1 | 589.22M |